Contents:

Wound Treatments in Vietnam Euromonitor International May 2010 List of Contents and Tables Executive Summary Sales of Consumer Healthcare Products Increased During 2009 Drug Prices Increase During 2009 Competition Increases Between Domestic and Foreign Players Drugstores Dominate Distribution Sales Stable Consumer Healthcare Growth Projected for Forecast Period Key Trends and Developments Increasingly Strict Price Controls Rising Consumer Purchasing Power Rising Competition Between Domestic and Foreign Producers Rising Demand for Self Medication and Vitamin and Dietary Supplements Domestic Companies Strive To Improve Competitive Edge Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009 Table 2 Life Expectancy at Birth 2004-2009 Market Data Table 3 Sales of Consumer Health by Sector: Value 2004-2009 Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009 Table 5 Consumer Health Company Shares by Value 2005-2009 Table 6 Consumer Health Brand Shares by Value 2006-2009 Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009 Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009 Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014 Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014 Appendix OTC Registration and Classification Vitamins and Dietary Supplements Registration and Classification Self Medication/self-care and Preventative Medicine Generics Switches Definitions Sector and Subsector Definitions Summary 1 Research Sources Domesco - Dongthap Medical Import Export Corp Strategic Direction Key Facts Summary 2 Domesco - Dongthap Medical Import Export Corp: Key Facts Summary 3 Domesco - Dongthap Medical Import Export Corp: Operational Indicators Company Background Production Competitive Positioning Summary 4 Domesco - Dongthap Medical Import Export Corp: Competitive Position 2009 Haugiang Pharmaceutical Joint Stock Co Strategic Direction Key Facts Summary 5 Haugiang Pharmaceutical Joint Stock Co: Key Facts Summary 6 Haugiang Pharmaceutical Joint Stock Co: Operational Indicators Company Background Production Competitive Positioning Summary 7 Haugiang Pharmaceutical Joint Stock Co: Competitive Position 2009 Mekophar Chemical Pharmaceutical Jsc (mekophar) Strategic Direction Key Facts Summary 8 Mekophar Chemical Pharmaceutical JSC: Key Facts Summary 9 Mekophar Chemical Pharmaceutical JSC: Operational Indicators Company Background Production Competitive Positioning Summary 10 Mekophar Chemical Pharmaceutical JSC: Competitive Position 2009 Pharbaco - Central Pharmaceutical Factory No 1 Strategic Direction Key Facts Summary 11 Pharbaco - Central Pharmaceutical Factory No 1: Key Facts Summary 12 Pharbaco - Central Pharmaceutical Factory No 1: Operational Indicators Company Background Production Competitive Positioning Summary 13 Pharbaco - Central Pharmaceutical Factory No 1: Competitive Position 2009 Traphaco Joint Stock Co Strategic Direction Key Facts Summary 14 Traphaco Joint Stock Co: Key Facts Summary 15 Traphaco Joint Stock Co: Operational Indicators Company Background Production Competitive Positioning Summary 16 Traphaco Joint Stock Co: Competitive Position 2009 Trends Category Data Table 11 Sales of Wound Treatments by Subsector: Value 2004-2009 Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009 Table 13 Wound Treatments Company Shares by Value 2005-2009 Table 14 Wound Treatments Brand Shares by Value 2006-2009 Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014 Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014